Detalhe da pesquisa
1.
Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing COVID-19-Related Thromboembolic Events Among Medicare Enrollees Aged ≥65 Years and Those with End Stage Renal Disease - United States, September 2022-March 2023.
MMWR Morb Mortal Wkly Rep
; 73(1): 16-23, 2024 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38206877
2.
Use of Updated COVID-19 Vaccines 2023-2024 Formula for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2023.
MMWR Morb Mortal Wkly Rep
; 72(42): 1140-1146, 2023 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37856366
3.
Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions - VISION Network, September 2022-April 2023.
MMWR Morb Mortal Wkly Rep
; 72(21): 579-588, 2023 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37227984
4.
Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months-5 Years - VISION Network, United States, July 2022-June 2023.
MMWR Morb Mortal Wkly Rep
; 72(33): 886-892, 2023 Aug 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37590187
5.
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022.
MMWR Morb Mortal Wkly Rep
; 71(53): 1637-1646, 2023 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36921274
6.
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022.
MMWR Morb Mortal Wkly Rep
; 71(5152): 1616-1624, 2022 Dec 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36580430
7.
Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions - VISION Network, September 2022-April 2023.
Am J Transplant
; 23(7): 1062-1076, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37394267
8.
Risk of COVID-19 Hospitalization and Protection Associated With mRNA Vaccination Among US Adults With Psychiatric Disorders.
Influenza Other Respir Viruses
; 18(3): e13269, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38494192